Clinical Trials · NCT01452685
A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Takeda
- Enrollment
- 397
- Start date
- Mar 2012
- Locations
- 69 sites, Japan
- Primary endpoint
- Bone Mineral Density